Why Some Lung Tumors Respond Better To Targeted Therapies Than Others
December 07, 2022
December 07, 2022
NEW HAVEN, Connecticut, Dec. 7 (TNSjou) -- Yale School of Medicine posted the following news:
In a new study, Yale Cancer Center researchers found molecular explanations for why some lung tumors respond better to certain drugs than others. The research should help improve drug selection for lung cancer patients with different mutations in the EGF receptor, using a precision medicine approach to treatment.
The findings were recently published in Nature Communications.
In a new study, Yale Cancer Center researchers found molecular explanations for why some lung tumors respond better to certain drugs than others. The research should help improve drug selection for lung cancer patients with different mutations in the EGF receptor, using a precision medicine approach to treatment.
The findings were recently published in Nature Communications.